Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.83SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.310SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.362.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.162SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Y.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.86SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.154SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.4.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.41SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.137SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.446SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.76 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.1.398SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.163SYoung-STATACATGTCTCTGGGACCA20452176321782F-14517.8Singapore
P.3 (Theta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.38.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XAVSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.1.4.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBC.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BM.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.77SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CP.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
FC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BY.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.7.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
AY.123 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.71SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.12.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DN.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.177.51SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XRSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.350.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.254SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.39.1.1 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.418SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.9.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.40SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.122SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XAJSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.431SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.168SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Q.6 (Alpha)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
AZ.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.97SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used